INSIGHTS ON CLINICAL TRIAL PARTNERING

• Small But Growing Biotech Manages Disclosure, Maintains Compliance, And Keeps Its Promise To Patients

  For this biotech, the big challenge was both a lack of expertise and resources needed to manage registration of trials and posting results. TrialScope provided a proven solution that optimizes the efficiency of disclosure activities, maximizes trial data transparency, and fosters more informed, engaged patients through open research sharing.

• Lengthy Cancer Drug Study Using Dozens Of Sites Yields Positive Results

  After lengthy recruiting process and a five year long clinical trial spread across more than two dozen sites, sponsor calls study results “an unexpectedly huge step forward” in overcoming the limited efficacy of current treatments and continues partnership with CRO.

• Removing Barriers To Specialty Therapies

  Gaining access to specialty medications requires navigating multiple complex pathways, including determining insurance coverage options, co-pay amounts, the patient’s total cost of therapy, prior authorizations, and appeals. Obstacles along each path can lead to increased turnaround time and drive script abandonment. Technology brings advancements for removing these barriers, but buyer beware.

• Innovative Recruitment And Retention Strategies For Phase III Rare Cardiovascular Disease Study

  A Phase III, placebo-controlled, double blind, randomized clinical study of pulsed inhaled nitric oxide targeting rare cardiovascular disease was facing challenges. A partnership helped them solve their issues with patient recruitment, organizational effectiveness and regional patient expertise.

• Bringing Transparency And Collaboration To CRO Oversight

  Because sponsors often have multiple studies running concurrently with multiple CROs, oversight is complicated, as each CRO has its own method for study startup and for transmitting information back to the sponsor. By transitioning to a solution used by all CROs across the portfolio, oversight improves, and sponsors can build reliable institutional knowledge about CRO performance.

• Mitigating Inherent Risks In Global Sample Processing

  The global demand for specialized sample processing has grown dramatically however despite the rising need, research teams continue to struggle to obtain high-quality laboratory support services to perform sample processing. Learn how innovative flow cytometry fast turnaround and monitored, specialized processing can help safeguard samples.

• The Evolution Of Public Health Research: The Next Frontier

  Public health and medical research occasionally take unexpected turns that allow us to glimpse new wonders into the world we inhabit. Enlightened by the microbiome, those of us who support biomedical research by providing biological sample management have work to do.

• Increasing Volume Of Essential Clinical Supplies To Patients In Their Homes As Part Of Ongoing Response To COVID-19

  COVID-19 poses an unprecedented threat to the continuity of supply of vital medications to patients enrolled in clinical trials around the world. Providing a range of distribution options tailored to sponsors safeguards patients and maintains vital study timelines.

• The Perfect Remedy For Clinical Trial Distribution

  The distribution of Investigational Medicinal Products (IMPs) has become an increasingly complex part of the clinical supply chain. Download our white paper to understand why an effective distribution strategy is essential to a clinical trial’s success.